Oral administration results in lower systemic availability due to digestive enzymes, though the peptides stability allows local gastrointestinal effects at high concentrations which is why oral delivery is often preferred for BPC-157s gut healing applications
For GI-local effects, oral administration makes mechanistic sense
Results: DSIP-CBBBP demonstrates a capacity to modulate neurotransmitter levels, indicated by changes in 5-HT, glutamate, DA, and melatonin
This mechanism seems promising in labs
For combined protocols, mechanistic complementarity is well-established, but rigorous head-to-head solo-vs-combined data remains rare
In some embodiments, the formulation or composition comprises between about 0.01% to about 8% by weight of the viscosity modulating agent